药效评价The selective tachykinin neurokinin 1 (NK1) receptor antagonist, GR 205,171, stereospecifically inhibits light-induced phase advances of hamster circadian activity rhythms.
期刊:European journal of pharmacology发表年份:2005作者:Robert L Gannon; Mark J Millan
